comparemela.com

Latest Breaking News On - Amarin corporation - Page 6 : comparemela.com

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesUnited arab emiratesUnited kingdomGreat britainColl cardiolClin cardiolMark marmurNabil abadirJournal of the american college cardiologyExchange commissionA report from the american heart associationAmarin corporationEuropean unionDrug administrationAmerican heart association

Amarin Co plc (NASDAQ:AMRN) Short Interest Update

Amarin Co. plc (NASDAQ:AMRN – Get Free Report) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 18,190,000 shares, an increase of 7.1% from the February 29th total of 16,990,000 shares. Based on an average trading volume of 2,310,000 shares, the days-to-cover ratio […]

United statesUnited arab emiratesAmarin coRaymond james financial services advisors incAmarin corporationCantor fitzgeraldCapital management incMirae asset global investments coTokio marine asset management coGet free reportAsset global investmentsJames financial services advisorsMarine asset managementKallen investment managementManagement incUnited arab

Amarin Corp (AMRN) Issues Update on VAZKEPA Intellectual Property Portfolio in Europe

Amarin Corp (AMRN) Issues Update on VAZKEPA Intellectual Property Portfolio in Europe
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Patrick holtAmarin corporationEuropean patent officeCompany europeanSupplemental protection certificates

Amarin: IP Protection For VAZKEPA In Europe Now Extended Into 2039

Amarin Corporation plc (AMRN) announced it received a Decision to Grant from the European Patent Office for a new patent covering VAZKEPA that will extend VAZKEPA exclusivity eight additional years into 2039.

Patrick holtMore such health newsAmarin corporationEuropean patent office

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

DUBLIN, Ireland and BRIDGEWATER, N.J., April 03, 2024 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company received a Decision to Grant from the European Patent Office

New jerseyUnited statesMark marmurPatrick holtCompany europeanExchange commissionEuropean patent officeAmarin corporationSupplemental protection certificatesPrivate securities litigation reform actSecurities actContact informationMedia inquiries

vimarsana © 2020. All Rights Reserved.